A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer

Annals of Surgery

Volumn 259, Issue 4, 2014, Pages 656-664

  Jang, Jin Young ^a   Kang, Mee Joo ^a   Heo, Jin Seok ^b   Choi, Seong Ho ^b   Choi, Dong Wook ^b   Park, Sang Jae ^c   Han, Sung Sik ^c   Yoon, Dong Sup ^d   Yu, Hee Chul ^e   Kang, Koo Jeong ^f   Kim, Sang Geol ^g   Kim, Sun Whe ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

^c National Cancer Center   (United States)

^d Yonsei University College of Medicine   (South Korea)

^e Chonbuk National University Medical School   (South Korea)

^f Dongsan Medical Center   (South Korea)

^g Kyungpook National University School of Medicine   (South Korea)

Author keywords

Cancer; lymph node; nerve; pancreas; survival analysis

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; GEMCITABINE;

ABDOMINAL ABSCESS; ABDOMINAL BLEEDING; ADENOSQUAMOUS CARCINOMA; ADJUVANT CHEMORADIOTHERAPY; ADULT; ARTICLE; CANCER RECURRENCE; CANCER SIZE; CELIAC ARTERY; CONTROLLED STUDY; DIARRHEA; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; LONG TERM SURVIVAL; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAINTENANCE CHEMOTHERAPY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NERVE PLEXUS; NERVE SURGERY; OPERATION DURATION; OPERATIVE BLOOD LOSS; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS FISTULA; PANCREAS RESECTION; PANCREATIC HEAD CANCER; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SEPSIS; STOMACH EMPTYING; SUPERIOR MESENTERIC ARTERY; SURGICAL INFECTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CELIAC PLEXUS; CHEMORADIOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; GALLBLADDER; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MESENTERIC ARTERY, SUPERIOR; MIDDLE AGED; PANCREAS; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84895922590     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000384     Document Type: Article

References (26)

1. Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1999. CA Cancer J Clin. 1999;49:8-31.
2. Shin HR, Ahn YO, Bae JM, et al. Cancer incidence in Korea. Cancer Res Treat. 2002;34:405-408.
3. The Editorial Board of Cancer Statistics in Japan. Cancer Statistics in Japan 2005. Tokyo: Foundation for Promotion of Cancer Research; 2005.
4. Nitecki SS, Sarr MG, Colby TV, et al. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving Ann Surg. 1995;221:59-66.
5. Kang MJ, Jang JY, Lee SE, et al. Comparison of the long-term outcomes of uncinate process cancer and non-uncinate process pancreas head cancer: Poor prognosis accompanied by early locoregional recurrence. Langenbecks Arch Surg. 2010;395:697-706.
6. Fortner JG, Kim DK, Cubilla A, et al. Regional pancreatectomy: En bloc pancreatic, portal vein and lymph node resection. Ann Surg. 1977;186: 42-50.
7. Ishikawa O, Ohhigashi H, Sasaki Y, et al. Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg. 1988;208:215-220.
8. Manabe T, Ohshio G, Baba N, et al. Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas. Cancer. 1989;64:1132-1137.
9. Pedrazzoli S, DiCarlo V, Dionigi R, et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: A multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg. 1998;228:508-517.
10. Yeo CJ, Cameron JL, Sohn TA, et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: Comparison of morbidity and mortality and short-term outcome. Ann Surg. 1999;229:613-622; discussion 622-624.
11. Farnell MB, Pearson RK, Sarr MG, et al; Pancreas Cancer Working Group. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery. 2005;138:618-628; discussion 628-630.
12. Nimura Y, Nagino M, Takao S, et al. Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: Long-term results of a Japanese multicenter randomized controlled trial. J Hepatobiliary Pancreat Sci. 2012;19: 230-241.
13. Michalski CW, Kleeff J,Wente MN, et al. Systematic review andmeta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg. 2007;94:265-273.
14. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: Randomized controlled trial evaluating survival, morbidity and mortality. Ann Surg. 2002;236: 355-368.
15. Nguyen TC, Sohn TA, Cameron JL, et al. Standard versus radical pancreaticoduodenectomy for periampullary adenocarcinoma: A prospective randomized trial evaluating quality of life in pancreaticoduodenectomy survivors. J Gastrointest Surg. 2003;7:1-11.
16. Riall TS, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 3: Update on 5-year survival. J Gastrointest Surg. 2005;9:1191-1206.
17. Popiela T, Kedra B, Sierzega M. Does extended lymphadenectomy improve survival of pancreatic cancer patients Acta Chir Belg. 2002;102: 78-82.
18. Iacono C, Accordini S, Bortolasi L, et al. Results of pancreaticoduodenectomy for pancreatic cancer: Extended versus standard procedure. World J Surg. 2002;26:1309-1314.
19. Nakao A, Takeda S, Sakai M, et al. Extended radical resection versus standard resection for pancreatic cancer: The rationale for extended radical resection. Pancreas. 2004;28:289-292.
20. Kimura W. Strategies for the treatment of invasive ductal carcinoma of the pancreas and how to achieve zero mortality for pancreaticoduodenectomy. J Hepatobiliary Pancreat Surg. 2008;15:270-277.
21. Pawlik TM, Abdalla EK, Barnett CC, et al. Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. Arch Surg. 2005;140:584-589; discussion 589-591.
22. Nagakawa T, Kayahara M, Ueno K, et al. Clinicopathological study on neural invasion to the extrapancreatic nerve plexus in pancreatic cancer. Hepatogastroenterology. 1992;39:51-55.
23. Takada T. Surgery for carcinoma of the pancreas in Japan. Past, present, and future aspects. Digestion. 1999;60(suppl 1):114-119.
24. Miyazaki I, Kayahara M, Nagakawa T. [Changes in lymph node dissection for pancreatic cancer]. Nihon Geka Gakkai Zasshi. 1997;98:610-614.
25. Takahashi H, Ohigashi H, Ishikawa O, et al. Perineural invasion and lymph node involvement as indicators of surgical outcome and pattern of recurrence in the setting of preoperative gemcitabine-based chemoradiation therapy for resectable pancreatic cancer. Ann Surg. 2012;255:95-102.
26. Chaulagain CP, Ng J, Wazer D, et al. Adjuvant therapy of pancreatic cancer. JOP. 2012;13:349-353.